Subtle%20Shapes%20Transparent_edited.png

CASE STUDY

SP NETWORK FOR ORAL ONCOLYTIC WITH OTC COMPANION NEEDS

Case Studies > SP Network for Oral Oncolytic with OTC Companion Needs

How a new oncology therapy used a well-designed SP network to overcome AE concerns and exceed sales expectations.

SITUATION

Manufacturer’s first product was an oral oncolytic with a known side effect in approximately 50% of patients.

To mitigate the AE, the manufacturer wanted to ship an OTC medication with each Rx.

Legal Dept. was uncomfortable with paying for and providing OTC meds.

Needed an SP network with oncology centers of excellence that included care management to supply OTC medication.

APPROACH

We developed a very specific RFP to determine OTC care capabilities within oncology-focused SPs.

Our team managed the responses and interviews with the SPs and then conducted site visits to pressure test capabilities.

After a thorough analysis, an SP network was established and the OTC product is now shipped with each filled Rx.

RESULTS

The product has surpassed sales expectations.

The AE has not meaningfully impacted product success.

Pharmaceutical Consultants USA, Europe, Pharmaceutical Consulting Services USA, Europe, Biotech Consultants USA, Europe, Biotech Consulting Services USA, Europe, Pharmaceutical Market Access USA, Europe

SUBSCRIBE

Subscribe to receive news and updates from Archbow Consulting

Pharmaceutical and Biotech Consultancy Services in the USA and Europe

LET'S GET SOCIAL

CONTACT

USA Office

+1 (321) 355-2686

4700 Millenia Blvd., Suite 175, Orlando, FL 32839

Europe Office

+ 41 41 723 23 23

Dammstrasse 19 6300 Zug, Switzerland